Pierre-Simon Rohrlich
Overview
Explore the profile of Pierre-Simon Rohrlich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
911
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Suchon P, Soukarieh O, Bernard C, Mariotti A, Ernest V, Barthet M, et al.
J Thromb Haemost
. 2024 Dec;
23(3):997-1008.
PMID: 39675565
Background: Although heritability of venous thromboembolism (VTE) is high, the thrombophilia screening appears to be positive only in a minority of VTE patients. Adding rare variants screening to identify VTE...
2.
Thalhammer J, Jeziorski E, Marec-Berard P, Barkaoui M, Barkaoui M, Pagnier A, et al.
Blood
. 2024 Nov;
145(10):1061-1073.
PMID: 39486044
Hematological involvement (HI) is one of the life-threatening risk organs (ROs) in Langerhans cell histiocytosis (LCH). Lahey criteria have defined HI since 1975 as hemoglobin <10 g/dL, platelets <100 ×...
3.
Strullu M, Caye-Eude A, Robert E, Renard J, Chaye A, Galimand J, et al.
Leukemia
. 2024 Oct;
39(1):64-74.
PMID: 39420220
Genetic alterations are the cornerstone of risk stratification in B-cell precursor acute lymphoblastic leukemia (BCP-ALL), and their accurate identification is critical for optimal treatment. Most cases with ABL-class fusion are...
4.
Peyre M, Sicre de Fontbrune F, Berceanu A, Benjemia L, Castelle M, dAveni M, et al.
Bone Marrow Transplant
. 2024 Apr;
59(7):1034-1036.
PMID: 38605146
No abstract available.
5.
Jourdy Y, Chatron N, Fretigny M, Zawadzki C, Lienhart A, Stieltjes N, et al.
J Thromb Haemost
. 2024 Mar;
22(6):1616-1626.
PMID: 38484912
Background: No F8 genetic abnormality is detected in approximately 1% to 2% of patients with severe hemophilia A (HA) using conventional genetic approaches. In these patients, deep intronic variation or...
6.
Grain A, Rialland-Battisti F, Chevallier P, Blin N, Dalle J, Michel G, et al.
J Cancer Res Clin Oncol
. 2022 May;
149(4):1473-1483.
PMID: 35507103
Purpose: In the acute lymphoblastic leukemia (ALL) landscape, adolescents and young adults (AYA) often present high-risk diseases and increased chemotherapy-related toxicity. Studies analyzing the outcomes of AYA after hematopoietic stem...
7.
Machowicz R, Suarez F, Wiktor-Jedrzejczak W, Eikema D, de Wreede L, Blok H, et al.
Bone Marrow Transplant
. 2022 Mar;
57(5):817-823.
PMID: 35332305
Hemophagocytic lymphohistiocytosis (HLH; hemophagocytic syndrome) is a rare syndrome of potentially fatal, uncontrolled hyperinflammation. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is indicated in primary, recurrent or progressive HLH, but information...
8.
Sleurs C, Musoro J, Rowsell A, Kicinski M, Suciu S, Chantziara S, et al.
Cancers (Basel)
. 2022 Jan;
14(1).
PMID: 35008314
Background: due to increasing survival rates in childhood acute lymphoblastic leukemia (ALL), the number of survivors has been expanding. A significant proportion of these survivors can experience long-term emotional and...
9.
Rouger-Gaudichon J, Bertrand Y, Boissel N, Brethon B, Ducassou S, Gandemer V, et al.
Bull Cancer
. 2021 Mar;
108(5):490-500.
PMID: 33781551
Since the emergence of the SARS-CoV-2 infection, many recommendations have been made. However, the very specific nature of acute lymphoblastic leukemias and their treatment in children and adolescents led the...
10.
Tabone M, Kolta S, Auquier P, Vercasson C, Chastagner P, Kanold J, et al.
Hemasphere
. 2021 Jan;
5(2):e518.
PMID: 33458594
This prospective study aimed to analyze determinants that can influence bone mineral density evolution in childhood acute leukemia survivors. Patients included were selected from the long-term follow-up LEA cohort and...